How much upside does the new target imply?

The new target implies over 20% upside from the current trading price of around $415.

Why did analysts raise the price target?

The main reason is the impressive Q2 results that beat expectations.

Have other investment banks updated their ratings?

The report only mentions Truist, Oppenheimer, and KeyBanc, but others may follow.

UnitedHealth Stock: Analysts Raise Target to $500

Three investment banks raised their price target for UnitedHealth (UNH) to $500, citing impressive Q2 results and over 20% upside potential.

July 20, 2026

2 min read

Source: Stocktwits

Key Numbers

target price

$500

upside potential

over 20%

Analysts at Truist, Oppenheimer, and KeyBanc have raised their price target for UnitedHealth (UNH) to $500, signaling over 20% upside from current levels.

Rating Change

Truist, Oppenheimer, and KeyBanc each set a $500 price target for UNH with a Buy rating. The previous targets were not disclosed.

Analyst Rationale

Oppenheimer described Q2 results as "impressive," noting that UnitedHealth "handily" beat expectations. Analysts highlighted the company's strong performance in health insurance and healthcare services.

Context

The upgrade follows UnitedHealth's Q2 earnings beat. The stock currently trades near $415, implying over 20% upside to the new target. Other analysts may follow suit in the coming days.

What to Make of It

The price target upgrades from three major banks reflect growing confidence in UnitedHealth's performance after a strong Q2. However, investors should consider potential risks such as regulatory changes in the healthcare sector.

Frequently Asked Questions

Analysts at Truist, Oppenheimer, and KeyBanc raised the price target to $500.

Found this useful? Share it

This article was rewritten in Wrqti's editorial style based on information from the original source above. Content is informational only — not investment advice.